Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study

Background and Objectives: Intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute ischemic stroke (AIS) within 3 h after onset and the treatment was then extended to 4.5 h. However, the Food and Drug Administration did not approve the indication in the expanded time...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Autores principales: Chen, Yu-Wei, Sung, Sheng-Feng, Chen, Chih-Hung, Tang, Sung-Chun, Tsai, Li-Kai, Lin, Huey-Juan, Huang, Hung-Yu, Po, Helen L., Sun, Yu, Chen, Po-Lin, Chan, Lung, Wei, Cheng-Yu, Lee, Jiunn-Tay, Hsieh, Cheng-Yang, Lin, Yung-Yang, Yeh, Shoou-Jeng, Lien, Li-Ming, Jeng, Jiann-Shing
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803783/
https://ncbi.nlm.nih.gov/pubmed/31681138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.01038
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares